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Abstract
Photo cross-linking of proteins with short RNA oligomers is a classical method to study RNA–protein interactions that are
implicated in many aspects of RNA metabolism and function. Most commonly, this involves the use of [c-32P]-labeled RNA
probes. Although very sensitive, these procedures are complicated by the safety issues associated with the use of radioiso-
topes. Here, we describe a modified UV cross-linking method using oligonucleotide probes end labelled with the infrared
dye IRDyeVR 800. After UV cross-linking, proteins are separated by SDS-PAGE and cross-linked products are visualized with
the OdysseyVR Infrared Imaging system. This end labelling approach provides a streamlined alternative to random labelling
which reduces the efficiency of in-vitro transcription. End labelling is also independent of the length of the probe, thus facili-
tating quantitative comparisons. To validate the method, we have confirmed the binding of HuD to the 30-UTR of the mRNA
for the microtubule-associated protein tau, implicated in the pathogenesis of Alzheimer’s disease. UV cross-linking of HuD
with a labeled 21-mer probe was successfully performed using a recombinant purified glutathione-S-transferase–HuD fu-
sion protein as well as with lysates from CHO cells transfected with HuD cDNA. UV cross-linking combined with infrared
imaging offers a convenient and robust strategy to analyse RNA–protein interactions and their emerging importance in
disease.
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Introduction
All aspects of RNA metabolism and function, including pre-
mRNA splicing, mRNA stability and subcellular localization are
regulated by RNA-binding proteins (RBPs, also referred to as
trans-acting factors) binding to specific elements in the target
RNA [1]. RBPs interact with RNA through specific RNA-binding
domains, such as RNA-recognition motifs (RRMs), K-homology
domains or zinc fingers [2]. Importantly, abnormal binding of
RBPs to RNA has been linked to many pathological conditions,
especially neurodegenerative diseases (for reviews see [3, 4]).
Understanding the physiological function and pathological
role of RBPs requires a reliable assay to demonstrate binding of
specific proteins to RNA substrates. A popular method to study
the interaction between an RBP and a specific RNA sequence in-
volves UV cross-linking of the protein with a [c-32P]-labelled
RNA probe [5]. UV irradiation induces the formation of a
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covalent bond between pyrimidine bases in a short (20–25 mer)
RNA probe and specific amino acids (e.g. cysteine, lysine, phe-
nylalanine, tryptophan, tyrosine) of an RBP at sites of direct con-
tact with the probe. The covalent RNA–protein bond is
maintained after separation by SDS-PAGE allowing detection of
labelled RBPs. Although UV cross-linking using radiolabelled
probes is very sensitive, the procedure is complicated by the
safety issues associated with the use of radioisotopes. An alter-
native method using near-infrared dye labelled probes has been
described, but this method uses a random labelling procedure
that reduces the efficiency of in-vitro transcription 5-fold in the
presence of labelled UTPs [6]. To circumvent this problem, we
aimed to validate a streamlined method whereby the RNA probe
is commercially end labelled with the infrared dye IRDyeVR 800.
Cross-linked products are visualized after separation by SDS-
PAGE with the OdysseyVR Infrared Imaging system from LI-COR
Biosciences (Cambridge, UK).
To validate the method, we confirmed the binding of HuD to
the 30-UTR of tau mRNA. Tau is a microtubule-associated pro-
tein predominantly expressed in neurons and enriched in
axons. Its primary function is to promote microtubule polymeri-
zation and stabilization, and it regulates a number of
microtubule-dependent processes such as axonal transport [7].
Importantly, tau accumulates in characteristic intracellular fila-
mentous inclusions in several neurodegenerative diseases col-
lectively referred to as the tauopathies (which include
Alzheimer’s disease) [8, 9]. Tau mRNA has a long 30-UTR that
contains specific elements regulating mRNA localization and
stability. Several trans-acting factors that associate with the 30-
UTR of tau mRNA have been identified, including HuD, an em-
bryonic lethal abnormal vision-like family protein with three
RRMs, which regulates the stability of tau mRNA [10–12].
UV cross-linking combined with infrared imaging using the
OdysseyVR system offers a convenient and robust strategy of
general applicability to not only demonstrate but also charac-
terize RNA–protein interactions. This procedure will be particu-
larly useful to analyse the properties of RBPs involved in
disease, or conversely to confirm the binding of specific RBPs to
RNA sequences linked to disease (e.g. [13]).
Materials and methods
Expression vectors
cDNA clones for human HuD and rat Tra2b were the generous
gifts of Dr Bernard Jasmin (University of Ottawa, Ottawa,
Ontario, Canada) and Dr Stefan Stamm (University of Kentucky,
Lexington), respectively. cDNAs were subcloned into the expres-
sion vector pCMV-tag3B to tag both HuD and Tra2b with a
c-myc epitope at their N-terminus. For production of glutathi-
one-S-transferase (GST)–HuD fusion protein HuD cDNA was
cloned into pGEX-4T-1.
Production of recombinant GST–HuD fusion protein
The Escherichia coli strain BL21 (DE3) was transformed with
pGEX-4T-1 encoding either GST alone or GST–HuD fusion pro-
tein. Bacteria were grown at 37C until an OD550 of 0.6–0.9 was
reached. Protein expression was induced by adding 1 mM iso-
propyl b-D-1-thiogalactopyranoside. After overnight incubation
at 22C, bacteria were lysed in lysis buffer [25 mM Tris–HCl, pH
7.4, 0.1 M NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA),
lysozyme (0.4 mg/ml), 2 mM phenylmethylsulfonyl fluoride,
1 mM benzamidine, 1 mM Dithiothreitol (DTT) and CompleteVR
mini protease inhibitor cocktail], followed by sonication. After
centrifugation, GST–HuD fusion protein was bound to
glutathione-4B beads (GE Healthcare Life Sciences,
Buckinghamshire, UK), in TNE buffer (25 mM Tris–HCl, pH 7.4,
0.1 M NaCl, 1 mM EDTA and CompleteVR mini protease inhibitor
cocktail), and eluted with 1 ml of elution buffer (20 mM reduced
glutathione, 0.2% (v/v) b-mercaptoethanol and 50% (v/v) glycerol
in TNE buffer). Protein concentrations were determined using
the Bradford protein assay (Bio-Rad Laboratories).
Cell culture and transfection
CHO cells were cultured in Ham’s F-12 medium supplemented
with 10% (v/v) fetal bovine serum, 2 mM L-glutamine and
100 units/ml penicillin. Cells were maintained at 37C in a hu-
midified atmosphere of 5% CO2/95% air. Cells were seeded in
6-well plates and transfected using the jetPEITM reagent
(PolyPlus-transfection, Illkirch, France) according to the
manufacturer’s instructions. Cells were analysed 24 h after
transfection. After transfection cells were rinsed with phos-
phate- buffered saline (PBS) at 4 C and lysed for 30 min in ex-
traction buffer [10 mM HEPES, 3 mM MgCl2, 14 mM KCl, 5% (v/v)
glycerol, 0.2% (v/v) Nonidet P-40, 1 mM DTT and CompleteVR Mini
protease inhibitor cocktail (Roche)]. The lysates were centri-
fuged at 10 000 rpm for 5 min at 4C and the supernatant was
collected and protein concentration was measured using the
Bradford protein assay (Bio-Rad Laboratories).
UV cross-linking
The F21 RNA probe (50-CUUUUUUUUUUUUUACUUUAG-30) was
synthesized with an IRDyeVR 800CW NHS Ester 50 modification by
Integrated DNA Technologies (Coralville, IA, USA). UV cross-
linking was performed as follows: all steps were performed at
room temperature and protected from light unless otherwise
stated. Recombinant protein (500 ng) or cell lysate (20–40 mg)
was incubated with labelled F21 probe (40 pmol) in a reaction
volume of 20–30 ll in extraction buffer for 30 min at room tem-
perature. Subsequently, 0.3 U of RNase T1 (Roche Diagnostics
Ltd) was added to the RNA–protein mixture and samples
were incubated for 10 min, followed by incubation with heparin
(5 mg/ml, Sigma–Aldrich) for an additional 10 min at room tem-
perature. The mixture was transferred to a 96-well plate and
placed on ice 1–2 cm from the UV light source (254 nm) and irra-
diated at 3 105 mJ in a StratalinkerVR UV Crosslinker Model 2400
(Stratagene). RNase A (0.1 mg/ml, Roche Diagnostics Ltd) was
then added and the mixture was incubated for 15 min at 37C.
Finally, samples were mixed 1:1 with 2 SDS-PAGE sample buf-
fer and heated at 100C for 5 min. A total of 10–20 ml of the reac-
tions were loaded on 10% (w/v) polyacrylamide gels and
proteins were separated by SDS-PAGE along with Precision Plus
Protein Standards (All Blue) (Bio-Rad Laboratories). RNA–protein
complexes were detected by scanning the gel at 700 nm and
800 nm using the OdysseyVR Infrared Imaging system (LI-COR
Biosciences).
SDS-PAGE and western blotting
For western blotting, proteins separated by SDS-PAGE were
transferred to nitrocellulose membranes. After blocking in 5%
(w/v) skimmed milk/0.1% (v/v) Tween-20 in PBS for 1 h mem-
branes were incubated with mouse monoclonal anti-c-myc an-
tibody (Sigma) overnight at 4C in blocking solution followed by
AlexaFluor 680 goat anti-mouse IgG (Molecular Probes).
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Immunoreactivity was detected by scanning membranes at
700 nm using the OdysseyVR Infrared Imaging system.
Results and discussion
HuD binds to a U-rich region in the 30-UTR of tau mRNA, within
a 91 base stem loop structure responsible for the selective locali-
zation of tau mRNA to the axon. This region is referred to as the
axonal-targeting element (ATE) [10, 14–16]. A 21 base-long RNA
probe, F21, corresponding to nucleotides 2574–2595 of rat tau
mRNA and comprising the U-rich sequence within the ATE in
the 30-UTR of tau mRNA was synthesized and labelled at its
50-end with IRDyeVR 800 fluorochrome (Fig. 1A).
UV cross-linking of HuD with the IRDyeVR 800-labelled probe
was first performed using a purified recombinant GST–HuD fu-
sion protein. After UV cross-linking, proteins were separated by
SDS-PAGE and the gel was scanned directly with the OdysseyVR
imager. Two fluorescent bands were detected in reactions con-
taining GST–HuD and were absent from reactions containing GST
only (Fig. 1B, left panel). The major fluorescent band migrated at
the expected molecular weight for GST–HuD (Fig. 1B, right panel)
and represents the full-length fusion protein. The minor band
likely corresponds to a degradation product of the fusion protein.
To further assess the general applicability of the method, UV
cross-linking with the IRDyeVR 800-labeled tau probe was per-
formed using lysates from CHO cells transfected with c-myc-
tagged HuD cDNA. Mock-transfected cell lysates were used as a
negative control. After UV cross-linking, proteins were sepa-
rated by SDS-PAGE and cross-linked products were visualized
as above. A fluorescent band of 40 kDa was present in the sam-
ples from HuD-transfected cells, but not in samples from mock-
transfected cells (Fig. 1C, left panel). This band corresponds to
the molecular weight of HuD and co-migrates with HuD
detected by western blotting using anti-c-myc antibody (Fig. 1C,
right panel).
As a control for the specificity of cross-linking, the same
analysis was performed using lysates from CHO cells trans-
fected with another RBP, transformer 2b (Tra2b). Western blot-
ting of CHO cell lysates transfected with c-myc-tagged Tra2b
confirmed Tra2b expression, visualized as a single 40 kDa
band (Fig. 1D, right panel). Fluorescence analysis of the gel did
not reveal any interaction between Tra2b and the IRDyeVR 800-
labelled F21 probe when scanned at high exposure. There was
no fluorescent band corresponding to the molecular weight of
Tra2b and there were no differences in the background (present
as a result of over exposure) observed between Tra2b-trans-
fected cells and mock-transfected cells (Fig. 1D, left panel).
Taken together, we have validated the use of commercially
produced end labelled fluorescent probes for UV cross-linking
by confirming the specific binding of HuD to the 30-UTR of tau
mRNA. At least three biological replicates were performed dur-
ing validation. All replicates demonstrated a highly similar and
definitive presence/absence of signal to the protein being tested
indicating a high reproducibility.
The activity and specificity of RNases in RNA–protein in-
teraction studies is worth careful consideration. We have
used RNases with sequence specificity to help avoid over di-
gestion and digestion of the probe. Firstly, before UV irradia-
tion, RNase T1 was used which cleaves specifically at the
30-end of guanosines (the sequence of our probe contained a
single guanosine at the 30-end). This helps to disrupt large
messenger ribonucleoprotein complexes and reduces compe-
tition between other abundant RNAs present in the cell ly-
sate. Secondly, after UV irradiation, RNase A was added
which cleaves at the 30-end of pyrimidines to ensure all un-
bound probe is digested.
Figure 1: UV cross-linking demonstration of HuD binding to the 30-UTR of tau mRNA. (A) Structure of tau mRNA. The 21 base-long HuD binding site (blue), which is en-
compassed within the ATE (red) in the 30-UTR of tau mRNA, was used as an RNA probe (F21). ORF: open reading frame. (B) Left panel: UV cross-linking analysis showing
a direct binding of the IRdyeVR 800-labelled F21 probe to recombinant GST–HuD. Right panel: Coomassie blue stained gel of purified GST–HuD fusion protein.
(C) Analysis of lysates from CHO cells transfected with c-myc-tagged HuD by UV cross-linking with the F21 probe. Binding of the F21 probe to HuD is detected in HuD-
transfected cells but not in mock-transfected cells (left panel). Cell lysates were analysed by western blotting with anti-c-myc antibody confirming the molecular
weight of HuD (right panel, arrowhead). (D) Analysis of lysates from CHO cells transfected with c-myc-tagged Tra2b by UV cross-linking with the F21 probe. Only non-
specific background and no binding of the F21 probe to Tra2b were observed (left panel, the gel was intentionally scanned at high resolution to show absence of prod-
ucts co-migrating with Tra2b). Cell lysates were analysed by western blotting with an anti-c-myc antibody confirming expression and molecular weight of Tra2b (right
panel, arrowhead). Images are representative of at least three biological replicates.
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The photostability of IRDyeVR infrared dyes is good-excellent
depending on the dye used. Our experience is that there is no
significant photobleaching using an OdysseyVR infrared scanner
and IRDyeVR (s) for UV cross-linking and western blotting applica-
tions (where repetitive scanning is not typically required).
IRDyeVR 800CW has a measured fluorescence decay rate of 1.73
kz (bleached dye/s) [17]. Although not currently available for
commercial end labelling, the use of extremely photostable
IRDyeVR infrared dyes such as IRDyeVR 700DX (measured fluores-
cence decay rate of 0.024 kz bleached dye/s) [17] alongside
significantly less photostable dyes may require further consid-
eration for comparative studies. Standard operating procedures
should always mitigate against photobleaching by the inclusion
of a positive control (e.g. HuD for the 30-UTR of tau mRNA) and
by performing the experiment over a short timeframe in the
dark.
As UV cross-linking is typically performed on short RNA
probes, end labelling of the probes is the method of choice. End
labelling offers several advantages over the random incorpora-
tion of labelled UTPs for UV cross-linking applications. Firstly,
our streamlined approach removes the difficulties (namely effi-
ciency and reproducibility) associated with in-vitro transcribing
intact full-length probes in the presence of labelled UTPs [6].
Our method requires minimal optimization and reduces the
number of steps and reagent handling. Although a higher de-
gree and specific activity of labelling can be achieved by ran-
domly labelling nucleic acids, with end labelling the intensity of
the signal is independent of the length of the probe. This facili-
tates fully quantitative comparisons and offers a greater appli-
cability for example with hybridization experiments. The wide
availability of sensitive fluorescent imagers in effect circum-
vents the need for the extra intensity that would be afforded by
random labelling. In line with others [6], we determined that as
little as 80 fmol of IRDyeVR 800 is required for detection using an
OdysseyVR infrared scanner. Our method uses 40 pmol of com-
mercially synthesized end-labelled probes, well above the limit
of sensitivity. Furthermore, multiple probes would reliably have
the same signal strength and sensitivity limit. We demonstrate
using the OdysseyVR Infrared Imaging system that the IRdyeVR 800
end labelling of probes is sufficient to identify and characterize
RNA–protein interactions. The use of such dyes additionally al-
lows for the identification of multiple RNA–protein interactions
from the same sample using alternatively coloured probes.
Our work establishes the value of UV cross-linking with fluo-
rescently end-labelled probes combined with infrared imaging
to study RNA–protein interactions. We have streamlined a UV
cross-linking method that will be of value to researchers wish-
ing to identify and characterize the emerging role of RNA–pro-
tein interactions in disease.
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